Gout and Uric & Nucleic Acids
Online ISSN : 2435-0095
Review
Mechanism of inhibition of xanthine oxidoreductase by drugs and food components
Sae IchinoKen Okamoto
Author information
JOURNAL FREE ACCESS

2023 Volume 47 Issue 1 Pages 1-8

Details
Abstract
Xanthine oxidoreductase (XOR) is one of the major targets for urate-lowering drugs. Inhibition of XOR reduces uric acid production, resulting in anti-gout effects. Studies of XOR-inhibitor interactions have revealed factors important in binding to the enzyme. Many foods have been reported to have urate-lowering properties, and various plant origine flavonoids have been shown to inhibit XOR. However, the Ki values of these compounds are 104 times higher than those of febuxostat. The crystal structure of XOR bound to quercetin reveals a lack of hydrogen bonding between the nitrile group and the asparagine residue of the enzyme, which is essential for potent inhibitory activity. These findings are expected to contribute to the development of new XOR inhibitors using flavonoids as lead compounds.
Content from these authors
© 2023 Japanese Society of Gout and Uric & Nucleic Acids
Previous article Next article
feedback
Top